STAT3 and obesity due to melanocortin 4 receptor deficiency: While STAT3 is a well-established role player in multiple types of cancer [34], recent evidence indicates the importance of STAT3 signaling pathways in obesity-associated cancers and indirectly suggests that diabetes could enhance cancer development via STAT3 activation [35].